Imricor Medical Systems Inc - Chess Depository Int

NEW
ASX:IMR (USA)   Chess Depository Interest
A$ 1.13 (-0.88%) Dec 12
At Loss
P/B:
0
Market Cap:
A$ 308.00M ($ 196.92M)
Enterprise V:
A$ 323.34M ($ 206.72M)
Volume:
163.39K
Avg Vol (2M):
230.46K
Warning! GuruFocus detected 9 Severe warning signs with IMR. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
163.39K
Market Cap A$:
308.00M
Market Cap $:
196.92M
At Loss
Avg Vol (2M):
230.46K
Enterprise Value A$:
323.34M
Enterprise Value $:
206.72M
PB Ratio:
0
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Imricor Medical Systems Inc
NAICS : 334510 SIC : 3845
ISIN : AU0000054942
https://www.imricor.com
400 Gateway Boulevard, Burnsville, MN, USA, 55337

Share Class Description:

ASX:IMR: Chess Depository Interest
Compare
Compare
ASX:EMVASX:MX1ASX:SOMASX:UBIASX:NTIASX:4DXASX:EYEASX:RSHASX:CYCASX:CMPABTSYKMDTBSXSZSE:300760EWDXCMZBHSTEXAMS:PHIA
Traded in other countries / regions
IMR.Australia
IPO Date
2019-08-30
Description
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Financial Strength

1/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.84
Debt-to-Equity -1.77
Debt-to-EBITDA -0.59
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -20.58
Distress
Grey
Safe
Beneish M-Score -1.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -9.1
3-Year EBITDA Growth Rate -14.1
3-Year EPS without NRI Growth Rate -12.9
3-Year FCF Growth Rate 7.1
Future 3-5Y EPS without NRI Growth Rate Estimate 46.18
Future 3-5Y Total Revenue Growth Rate Estimate 212.77

Momentum Rank

3/10
Name Current Vs Industry Vs History
5-Day RSI 54.28
9-Day RSI 58.89
14-Day RSI 61.29
3-1 Month Momentum % 70.59
6-1 Month Momentum % 100
12-1 Month Momentum % 67.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.46
Quick Ratio 0.8
Cash Ratio 0.53
Days Inventory 402.69
Days Sales Outstanding 131.06
Days Payable 322.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.6
Shareholder Yield % -7.11

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -126.19
Operating Margin % -2157.94
Net Margin % -2632.87
FCF Margin % -1930.44
ROA % -252.05
ROIC % -287.38
3-Year ROIIC % 3409.89
ROC (Joel Greenblatt) % -556.77
ROCE % -428.38

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 166.71
EV-to-EBIT -10.66
EV-to-EBITDA -11.06
EV-to-Revenue 280.43
EV-to-Forward-Revenue 4.87
EV-to-FCF -14.77
Price-to-GF-Value 2.97
Earnings Yield (Greenblatt) % -9.38
FCF Yield % -6.88

Financials

ASX:IMR's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Imricor Medical Systems Inc Executives

Details

GF Value: A$0.38

ASX:IMR

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 1.153
EPS (TTM) (A$) -0.17
Beta 0.82
3-Year Sharpe Ratio 0.34
3-Year Sortino Ratio 0.61
Volatility % 91.14
14-Day RSI 61.29
14-Day ATR (A$) 0.086969
20-Day SMA (A$) 1.0325
12-1 Month Momentum % 67.92
52-Week Range (A$) 0.41 - 1.375
Shares Outstanding (Mil) 270.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Imricor Medical Systems Inc Filings

Filing Date Document Date Form
No Filing Data

Imricor Medical Systems Inc Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Imricor Medical Systems Inc Frequently Asked Questions

What is Imricor Medical Systems Inc(ASX:IMR)'s stock price today?
The current price of ASX:IMR is A$1.13. The 52 week high of ASX:IMR is A$1.38 and 52 week low is A$0.41.
When is next earnings date of Imricor Medical Systems Inc(ASX:IMR)?
The next earnings date of Imricor Medical Systems Inc(ASX:IMR) is .
Does Imricor Medical Systems Inc(ASX:IMR) pay dividends? If so, how much?
Imricor Medical Systems Inc(ASX:IMR) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.